MultiCell Technologies Inc (MCET)

[Dip66]

Good post from a member on yahoo finance (MCET)

Bio-stent is not even the main factor that's the after thought , MCT-125 passed clinical trial phase 2 with flying colors using a double blind placebo test on over 100 MS patients suffering from sever fatigue , they are now going to phase 3 using 1000 to 3000 MS patients then is commercialization and then market .

Then they will be the only company on the F'n planet with the cure , patents and intellectual property rights until the patent expires in 10 years . they plan to generate 3 billion dollars in that time .

Then their is MCT 485 RNA therapy to cure liver cancer , please do your own DD Less